Adverse Drug Events Associated With Remdesivir in Real-World Hospitalized Patients With COVID-19, Including Vulnerable Populations: A Retrospective Multicenter Study-Reference-Cited by-同舟云学术

Adverse Drug Events Associated With Remdesivir in Real-World Hospitalized Patients With COVID-19, Including Vulnerable Populations: A Retrospective Multicenter Study

Published:2023 Issue:44 Volume:38 Page:
ISSN:1011-8934
Container-title:Journal of Korean Medical Science
language:en
Short-container-title:J Korean Med Sci

Author:

Kang Hyein¹²^ORCID,Kang Chang Kyung³^ORCID,Im Jae Hyoung⁴^ORCID,Cho Yoonsook⁵^ORCID,Kang Dong Yoon⁶^ORCID,Lee Ju-Yeun²^ORCID

Affiliation:

1. Infection Control Center, Seoul National University Hospital, Seoul, Korea.

2. College of Pharmacy, Seoul National University, Seoul, Korea.

3. Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.

4. Department of Internal Medicine, Inha University College of Medicine, Incheon, Korea.

5. Department of Pharmacy, Seoul National University Hospital, Seoul, Korea.

6. Department of Preventive Medicine, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, Korea.

Funder

Korea Institute of Drug Safety and Risk Management

Publisher

XMLink

Subject

General Medicine

Link

https://jkms.org/pdf/10.3346/jkms.2023.38.e346

Reference27 articles.

1. COVID-19 Treatment Guidelines Panel. Coronavirus disease 2019 (COVID-19) treatment guidelines. Updated 2022. Accessed August 17, 2022. https://www.covid19treatmentguidelines.nih.gov/

2. WHO coronavirus (COVID-19) dashboard. Updated 2020. Accessed November 30, 2022. https://covid19.who.int/

3. Gilead Sciences Inc. VEKLURY® intravenous injection (package insert). Updated 2020. Accessed December 12, 2022. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/214787Orig1s000lbl.pdf

4. How We Have Treated Severe to Critically Ill Patients With Coronavirus Disease 2019 in Korea

5. Treatment Options for Patients With Mild-to-Moderate Coronavirus Disease 2019 in Korea

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Remdesivir;Reactions Weekly;2024-01-20

2. Review of COVID-19 Therapeutics by Mechanism: From Discovery to Approval;Journal of Korean Medical Science;2024